Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : TRIPLE TRADES -- Ignore unavailable to you. Want to Upgrade?

To: yard_man who wrote (1398)	8/23/2021 10:37:13 AM
From: Bull RidaH	Respond to of 4424

SELL THE NEWS!!

To: yard_man who wrote (1398)	8/25/2021 12:05:56 AM
From: Bull RidaH	Read Replies (1) \| Respond to of 4424

Uhhhh... not so fast!!! About that approval... From www.Jimstone.is “The actual shot people know of as the "pfizer shot" never got approved. It stayed as "experimental". However, a second jab under a different name "Comirnaty" DID get "approved". Here's the kicker: Under emergency authorization the same old clotshot can be administered without approval until enough "Comirnaty" gets produced, apparently they have practically none, and they have millions of vials of the shot we all know and have come to love ready to go that can be completely used up before the "approved" version, (which is probably an identical weapon) HAS TO be used, with the previous one "discontinued". And as everyone knows, they threw procedure out the window and even Comirnaty has until Halloween 2025 to complete it's safety studies, all the while it will be administered without them. When I originally went over the approval document, it was a lengthy convoluted confusing snake speak script ALL THE WAY THROUGH. With an extended decipher done later, the above is precisely what it really says, in reality the "Pfizer shot" did NOT get approved but re-authorized for use until the tens of millions of shots already made are used, and then they'll switch to the "approved" Comirnaty version which has basically no clinical trials done on it, and are instead PENDING 2025. So that's great. That's all the time they need to get'er done.”